1. Home
  2. INAB vs MHUA Comparison

INAB vs MHUA Comparison

Compare INAB & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • MHUA
  • Stock Information
  • Founded
  • INAB 2016
  • MHUA 1990
  • Country
  • INAB United States
  • MHUA China
  • Employees
  • INAB N/A
  • MHUA N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • MHUA Medical Specialities
  • Sector
  • INAB Health Care
  • MHUA Health Care
  • Exchange
  • INAB Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • INAB 10.6M
  • MHUA 12.6M
  • IPO Year
  • INAB 2021
  • MHUA 2022
  • Fundamental
  • Price
  • INAB $1.63
  • MHUA $0.24
  • Analyst Decision
  • INAB Strong Buy
  • MHUA
  • Analyst Count
  • INAB 2
  • MHUA 0
  • Target Price
  • INAB $108.00
  • MHUA N/A
  • AVG Volume (30 Days)
  • INAB 72.9K
  • MHUA 654.0K
  • Earning Date
  • INAB 11-06-2025
  • MHUA 12-19-2025
  • Dividend Yield
  • INAB N/A
  • MHUA N/A
  • EPS Growth
  • INAB N/A
  • MHUA N/A
  • EPS
  • INAB N/A
  • MHUA 0.29
  • Revenue
  • INAB N/A
  • MHUA $89,547,563.00
  • Revenue This Year
  • INAB N/A
  • MHUA N/A
  • Revenue Next Year
  • INAB N/A
  • MHUA N/A
  • P/E Ratio
  • INAB N/A
  • MHUA $0.85
  • Revenue Growth
  • INAB N/A
  • MHUA N/A
  • 52 Week Low
  • INAB $1.53
  • MHUA $0.21
  • 52 Week High
  • INAB $12.53
  • MHUA $0.76
  • Technical
  • Relative Strength Index (RSI)
  • INAB 32.35
  • MHUA 39.96
  • Support Level
  • INAB $1.53
  • MHUA $0.22
  • Resistance Level
  • INAB $1.77
  • MHUA $0.26
  • Average True Range (ATR)
  • INAB 0.17
  • MHUA 0.02
  • MACD
  • INAB -0.02
  • MHUA 0.01
  • Stochastic Oscillator
  • INAB 12.28
  • MHUA 32.46

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: